Author: MedPro Systems

MedPro Systems Appoints Former Federal Prosecutor & Chief at the U.S. Attorney’s Office Maureen Ruane as Director, Compliance Advisory Services

MedPro Systems Appoints Former Federal Prosecutor & Chief at the U.S. Attorney’s Office Maureen Ruane as Director, Compliance Advisory Services

Strengthening MedPro’s In-House Compliance Expertise for Building, Maintaining and Enhancing Effective Compliance Programs for the Life Sciences Industry That Can Best Withstand and Potentially Avoid Government Scrutiny View the official press release here. MOUNT ARLINGTON, N.J., Sept. 19, 2023 — MedPro Systems, the leading provider of commercial and compliance solutions for the life sciences industry,…

2023 Transparency and Aggregate Spend Conference Insights

2023 Transparency and Aggregate Spend Conference Insights

The MedPro Systems team recently enjoyed attending Informa’s 2023 Transparency, Aggregate Spend & HCP Engagement conference in Washington, D.C. It was an excellent opportunity to connect with so many Life Sciences organizations, teams, and people we support, while keeping current on the newest challenges facing our industry. Access MedPro’s Presentations Our Key Takeaways: 1. CMS’s…

MedPro Systems Launches State Drug Price Reporting Reference Solution

MedPro Systems Launches State Drug Price Reporting Reference Solution

MOUNT ARLINGTON, N.J., Jan. 31, 2023 — MedPro Systems, the leading provider of commercial and compliance solutions for the Life Sciences industry, today launched an expansion to their authoritative transparency reference library solution, RegulatoryID, to cover US state drug price reporting regulations. With this expansion, pharmaceutical manufacturers can view and search all current and pending…

Webinar: Navigate State Drug Price Reporting with Ease

Webinar: Navigate State Drug Price Reporting with Ease

From launching a new product to adjusting existing price structures, it’s critical that pharmaceutical manufacturers are aware of how their pricing decisions can trigger state-level reporting obligations across the US. However, with more than 30 unique reporting requirements already enacted and more pending legislation on the way, it can be a daunting challenge to stay…

MedPro Systems Strengthens SAP Concur Partnership with New SAP Concur Endorsed Apps to Support Life Sciences Customers

MedPro Systems Strengthens SAP Concur Partnership with New SAP Concur Endorsed Apps to Support Life Sciences Customers

Delivering Integrated Search, Capture and Export of Accurate Healthcare License Data in Concur Expense and Concur Invoice to Comply with US and International Transparency Reporting Regulations Mount Arlington, N.J., November 03, 2022 — MedPro Systems, a leading provider of healthcare data, aggregate spend and compliance solutions to the Life Sciences industry, today announced an expansion…

MedPro Systems Webinar: Top 10 Transparency Mistakes Life Sciences Companies Should Avoid

MedPro Systems Webinar: Top 10 Transparency Mistakes Life Sciences Companies Should Avoid

With more than 30 years of experience and 700+ Life Sciences customers today, we’ve seen it all and we’re here to help! In this webinar, MedPro Systems regulatory experts cover the top 10 common transparency mistakes we’ve seen Life Sciences companies make and how to avoid them. Dive deep with the panel as they review…

Italy Implements New Transparency Reporting Regulations

Italy Implements New Transparency Reporting Regulations

Italian Sunshine Act Overview In May 2022, Italy approved a new national transparency law regulating relations between pharmaceutical & medical device manufacturers and people operating in the healthcare sector, including healthcare organizations. Unofficially dubbed the ‘Italian Sunshine Act,’ the law takes inspiration from US Federal Open Payments reporting (colloquially referred to as the ‘Sunshine Act’)…

MedPro Systems Webinar: Oregon’s New Pharma Rep Permanent Rule – What You Need to Know

MedPro Systems Webinar: Oregon’s New Pharma Rep Permanent Rule – What You Need to Know

On June 17, 2022, the state of Oregon released a Pharmaceutical Representative Licensure and Disclosure law requiring pharmaceutical representatives who do business with Healthcare Professionals (HCPs) within Oregon to acquire a license prior to marketing or otherwise promoting products to HCPs licensed in Oregon. In order to help businesses prepare to meet their obligations under…